A randomized double-blinded study of CRSwNP patients with comorbid asthma also found that omalizumab, a recombinant humanized monoclonal antibody targeting IgE, reduced nasal polyp size and improved sinus CT scores in patients with CRSwNP. The gene discussed is IGHE; the disease is chronic rhinosinusitis with nasal polyps.